Histogen Shares Outstanding 2012-2023 | HSTO
Histogen shares outstanding from 2012 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Histogen Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2022 | 3 |
| 2021 | 2 |
| 2020 | 0 |
| 2019 | 0 |
| 2018 | 0 |
| 2017 | 0 |
| 2016 | 0 |
| 2015 | 0 |
| 2014 | 0 |
| 2013 | 0 |
| 2012 | 0 |
| 2011 | 0 |
| Histogen Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-09-30 | 4 |
| 2023-06-30 | 4 |
| 2023-03-31 | 4 |
| 2022-12-31 | 3 |
| 2022-09-30 | 4 |
| 2022-06-30 | 2 |
| 2022-03-31 | 2 |
| 2021-12-31 | 2 |
| 2021-09-30 | 2 |
| 2021-06-30 | 2 |
| 2021-03-31 | 2 |
| 2020-12-31 | 0 |
| 2020-09-30 | 1 |
| 2020-06-30 | 0 |
| 2020-03-31 | 0 |
| 2019-12-31 | 0 |
| 2019-09-30 | 0 |
| 2019-06-30 | 0 |
| 2019-03-31 | 0 |
| 2018-12-31 | 0 |
| 2018-09-30 | 0 |
| 2018-06-30 | 0 |
| 2018-03-31 | 0 |
| 2017-12-31 | 0 |
| 2017-09-30 | 0 |
| 2017-06-30 | 0 |
| 2017-03-31 | 0 |
| 2016-12-31 | 0 |
| 2016-09-30 | 0 |
| 2016-06-30 | 0 |
| 2016-03-31 | 0 |
| 2015-12-31 | 0 |
| 2015-09-30 | 0 |
| 2015-06-30 | 0 |
| 2015-03-31 | 0 |
| 2014-12-31 | 0 |
| 2014-09-30 | 0 |
| 2014-06-30 | 0 |
| 2014-03-31 | 0 |
| 2013-12-31 | 0 |
| 2013-09-30 | 0 |
| 2013-06-30 | 0 |
| 2013-03-31 | 0 |
| 2012-12-31 | |
| 2012-09-30 | 0 |
| 2012-06-30 | 0 |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.001B | $0.004B |
| Histogen Inc. is a regenerative medicine company. It engages in developing patented technologies which replace and regenerates tissues in the body. The company's technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products. Histogen Inc., formerly known as Conatus Pharmaceuticals Inc., is based in San Diego, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $184.433B | 24.21 |
| Stryker (SYK) | United States | $124.840B | 29.94 |
| Boston Scientific (BSX) | United States | $108.315B | 33.74 |
| Medtronic (MDT) | Ireland | $107.408B | 15.20 |
| EssilorLuxottica (ESLOY) | France | $98.531B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.055B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.127B | 29.82 |
| ResMed (RMD) | United States | $31.587B | 29.66 |
| Terumo (TRUMY) | Japan | $24.910B | 35.18 |
| Koninklijke Philips (PHG) | Netherlands | $24.851B | 19.25 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.565B | 15.81 |
| Baxter (BAX) | United States | $20.486B | 14.94 |
| Insulet (PODD) | United States | $11.923B | 62.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.553B | 0.00 |
| Demant (WILYY) | Denmark | $10.525B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.816B | 23.28 |
| BellRing Brands (BRBR) | United States | $7.269B | 39.08 |
| Haemonetics (HAE) | United States | $4.679B | 23.93 |
| Lantheus Holdings (LNTH) | United States | $4.620B | 11.93 |
| Perrigo (PRGO) | Ireland | $4.458B | 12.75 |
| GN Store Nord (GNNDY) | Denmark | $4.097B | 26.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.531B | 16.69 |
| Envista Holdings (NVST) | United States | $3.394B | 14.01 |
| Green Thumb Industries (GTBIF) | United States | $2.781B | 88.13 |
| QuidelOrtho (QDEL) | United States | $2.654B | 9.63 |
| Neogen (NEOG) | United States | $2.653B | 25.52 |
| TG Therapeutics (TGTX) | United States | $2.454B | 69.04 |
| ICU Medical (ICUI) | United States | $2.395B | 17.87 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.117B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.911B | 0.00 |
| Owens & Minor (OMI) | United States | $1.839B | 17.65 |
| Verano Holdings (VRNOF) | United States | $1.731B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.499B | 49.47 |
| InMode (INMD) | Israel | $1.448B | 7.50 |
| National Vision Holdings (EYE) | United States | $1.386B | 43.17 |
| AdaptHealth (AHCO) | United States | $1.337B | 10.06 |
| AtriCure (ATRC) | United States | $1.198B | 0.00 |
| Warby Parker (WRBY) | United States | $1.187B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.147B | 0.00 |
| MacroGenics (MGNX) | United States | $0.973B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.792B | 0.00 |
| Evolus (EOLS) | United States | $0.790B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.743B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.673B | 14.54 |
| Phibro Animal Health (PAHC) | United States | $0.662B | 14.34 |
| Quanterix (QTRX) | United States | $0.631B | 0.00 |
| Jin Medical (ZJYL) | China | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.527B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.513B | 0.00 |
| PetIQ (PETQ) | United States | $0.497B | 18.54 |
| Surmodics (SRDX) | United States | $0.474B | 29.76 |
| ZimVie (ZIMV) | United States | $0.422B | 25.83 |
| Biote (BTMD) | United States | $0.421B | 4.01 |
| OraSure Technologies (OSUR) | United States | $0.408B | 6.75 |
| Aurora Cannabis (ACB) | Canada | $0.401B | 0.00 |
| Zynex (ZYXI) | United States | $0.374B | 51.17 |
| Viemed Healthcare (VMD) | United States | $0.324B | 32.12 |
| Cerus (CERS) | United States | $0.318B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.249B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 15.08 |
| Veru (VERU) | United States | $0.218B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.198B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.197B | 0.00 |
| Omeros (OMER) | United States | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.174B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.155B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.141B | 71.00 |
| InterCure (INCR) | Israel | $0.135B | 22.77 |
| FitLife Brands (FTLF) | United States | $0.128B | 20.56 |
| MariMed (MRMD) | United States | $0.114B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.113B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 8.70 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Brainsway (BWAY) | Israel | $0.093B | 0.00 |
| Chimerix (CMRX) | United States | $0.085B | 0.00 |
| Safety Shot (SHOT) | United States | $0.068B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.064B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.054B | 3.55 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.64 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Agape ATP (ATPC) | $0.023B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.015B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.015B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |